Preparation and characterization of starch-poly-ε-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications
Source abstract
Abstract
One limitation associated with the delivery of bioactive agents concerns the short half-life of these molecules when administered intravenously, which results in their loss from the desired site. Incorporation of bioactive agents into depot vehicles provides a means to increase their persistence at the disease site. Major issues are involved in the development of a proper carrier system able to deliver the correct drug, at the desired dose, place and time. In this work, starch-poly-epsilon-caprolactone (SPCL) microparticles were developed for use in drug delivery and tissue engineering (TE) applications. SPCL microparticles were prepared by using an emulsion solvent extraction/evaporation technique, which was demonstrated to be a successful procedure to obtain particles with a spherical shape (particle size between 5 and 900 microm) and exhibiting different surface morphologies. Their chemical structure was confirmed by Fourier transform infrared spectroscopy. To evaluate the potential of the developed microparticles as a drug delivery system, dexamethasone (DEX) was used as model drug. DEX, a well-known component of osteogenic differentiation media, was entrapped into SPCL microparticles at different percentages up to 93%. The encapsulation efficiency was found to be dependent on the polymer concentration and drug-to-polymer ratio. The initial DEX release seems to be governed mainly by diffusion, and it is expected that the remaining DEX will be released when the polymeric matrix starts to degrade. In this work it was demonstrated that SPCL microparticles containing DEX can be successfully prepared and that these microparticular systems seem to be quite promising for controlled release applications, namely as carriers of important differentiation agents in TE.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · biodegradable polymer synthesis and properties · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Biodegradable polymers as biomaterials
2. Starch-based biodegradable hydrogels with potential biomedical applications as drug delivery systems10.1016/S0142-9612(01)00322-2 ↗
3. Polysaccharide hydrogels for modified release formulations10.1016/j.jconrel.2007.01.004 ↗
4. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications10.1016/j.addr.2007.03.012 ↗
5. Structure-release rate correlation in collagen gels containing fluorescent drug analog10.1016/j.biomaterials.2005.05.032 ↗
6. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review10.1016/j.jconrel.2006.04.017 ↗
7. Hyaluronic acid: the scientific and clinical evidence10.1016/j.bjps.2007.03.005 ↗
8. Semisynthetic resorbable materials from hyaluronan esterification10.1016/S0142-9612(98)00042-8 ↗
9. Skeletal tissue engineering using silk biomaterials10.1002/term.68 ↗
10. Silk-based biomaterials10.1016/S0142-9612(02)00353-8 ↗
11. Preparation and characterization of chitosan microparticles intended for controlled drug delivery10.1016/S0378-5173(02)00487-8 ↗
12. Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug10.1016/j.jconrel.2005.04.005 ↗
13. Reis RL, Cunha AM. Starch Polymers. In: Buschow KHJ, Cahn RW, Flemings MC, Ilschner B, Kramer EJ, Mahajan S, Veyssie P, editors. Encyclopedia of materials: science and technology, vol. 11. New York: Elsevier Science; 2001. p. 8810–8816.
14. Biodegradable polymer scaffolds to regenerate organs10.1007/3540587888_18 ↗
15. New starch-based thermoplastic hydrogels for use as bone cements or drug-delivery carriers10.1023/A:1008944127971 ↗
16. Biocompatibility testing of novel starch-based materials with potential application in orthopaedic surgery: a preliminary study10.1016/S0142-9612(00)00395-1 ↗
17. Porous starch-based drug delivery system processed by a microwave route10.1163/156856201753395761 ↗
18. Boesel · 2003 · 243
19. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch based three-dimensional scaffolds10.1002/jbm.a.10075 ↗
20. Biodegradable polymers and composites in biomedical applications: from catgut to tissue engineering. Part I: Available systems and their properties10.1179/095066004225021918 ↗
21. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers10.1007/s10856-006-8240-z ↗
22. The biocompatibility of novel starch-based polymers and composites: in vitro studies10.1016/S0142-9612(01)00272-1 ↗
23. Cytocompatibility and response of osteoblastic-like cells to starch-based polymers: effect of several additives and processing conditions10.1016/S0142-9612(00)00377-X ↗
24. Alternative tissue engineering scaffolds based on starch: processing methodologies, morphology, degradation and mechanical properties10.1016/S0928-4931(02)00008-5 ↗
25. In vitro assessment of the enzymatic degradation of several starch based biomaterials10.1021/bm0300397 ↗
26. Azevedo · 2005 · 178
27. A novel enzymatically-mediated drug delivery carrier for bone tissue engineering applications: combining biodegradable starch-based microparticles and differentiation agents10.1007/s10856-008-3378-5 ↗
28. Chemo-occlusion for the treatment of liver cancer: a new technique using degradable starch microspheres10.2165/00003088-199426040-00004 ↗
29. Characterization of degradable starch microspheres as a nasal delivery system for drugs10.1016/0378-5173(90)90232-S ↗
30. Magnetic starch microspheres, biodistribution and biotransformation. A new organ-specific contrast agent for magnetic resonance imaging10.1097/00004424-199007000-00008 ↗
31. Entrapment ability and release profile of corticosteroids from starch-based microparticles10.1002/jbm.a.30287 ↗
32. Soluble starch and composite starch Bioactive Glass 45S5 particles: synthesis, bioactivity, and interaction with rat bone marrow cells10.1016/j.msec.2005.01.012 ↗
33. Starch-based microparticles as vehicles for the delivery of active platelet-derived growth factor10.1089/ten.2006.0194 ↗
34. Drug release from starch-acetate microparticles and films with and without incorporated α-amylase10.1016/j.biomaterials.2003.11.026 ↗
35. Polyacryl starch microparticles as adjuvants in oral immunization, inducing mucosal and systemis immune responses in mice10.1016/S0264-410X(02)00288-8 ↗
36. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant10.1016/j.vaccine.2003.09.034 ↗
37. Implantable drug delivery10.1177/088532829400800305 ↗
38. Advances in biomaterials, drug delivery, and bionanotechnology10.1002/aic.690491202 ↗
39. Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres10.1016/S0168-3659(00)00352-7 ↗
40. Development of poly-(d,l-lactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis10.1016/S0168-3659(01)00258-9 ↗
41. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy10.1016/S0960-8966(02)00180-3 ↗
42. Glucocorticoids suppress bone formation via the osteoclast10.1172/JCI28084 ↗
43. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels10.1208/aapsj070122 ↗
44. Materials in particulate form for tissue engineering. 2. Applications in bone10.1002/term.1 ↗
45. Osteogenic differentiation of human adipose-derived stem cells: comparison of two different inductive media10.1002/term.12 ↗
46. Conditioned media cause increases in select osteogenic and adipogenic differentiation markers in mesenchymal stem cell cultures10.1002/term.76 ↗
47. Thermal properties of thermoplastic starch/synthetic polymer blends with potential biomedical applicability10.1023/A:1022015712170 ↗
48. 1990 · 1
49. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region10.1016/S0168-3659(98)00029-7 ↗
50. Preparation of porous and nonporous biodegradable polymeric hollow microspheres10.1016/0168-3659(95)00010-6 ↗
51. Preparation and characterization of protein-loaded poly(ɛ-caprolactone) microparticles for oral vaccine delivery10.1016/S0378-5173(99)00109-X ↗
52. Biodegradable multiphase systems based on plasticized starch: a review10.1081/MC-200029326 ↗
53. FTIR study of polycaprolactone chain organization at interfaces10.1016/j.jcis.2004.02.001 ↗
54. Surface modification of starch based blends using potassium permanganate-nitric acid system and its effect on the adhesion and proliferation of osteoblast-like cells10.1007/s10856-005-6450-4 ↗
55. Synthesis and characterization of starch-modified polyurethane10.1016/j.carbpol.2006.08.017 ↗
56. Influence of formulation variables on the in vitro release of albumin from biodegradable microparticulate systems10.3109/02652049709051138 ↗
57. The preparation and characterization of poly(lactide-co-glycolide) microcapsules: III. Microparticle/polymer degradation rates and the in vitro release of a model protein10.1016/0378-5173(94)90201-1 ↗
58. The influence of biodegradable microcapsule formulations on the controlled release of a protein10.1016/0168-3659(94)90026-4 ↗
59. Cellulose acetate butyrate and polycaprolactone for ketoprofen spray-dried microsphere preparation10.3109/02652049409034256 ↗
60. Polymers for biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending10.3109/02652049309031524 ↗
61. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method10.1016/S0142-9612(00)00178-2 ↗
62. Protein release from poly(ε-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study10.1163/156856297X00380 ↗
63. Materials in particulate form for tissue engineering. 1. Basic concepts10.1002/term.2 ↗
64. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method10.1016/S0142-9612(03)00024-3 ↗